The FDA announced on Jan. 28, 2021, that Biomerieux Inc is recalling VITEK 2 Compact systems due to a potential safety risk of false susceptible test results. The agency stated the recall was voluntary and initiated by the firm.
How to tell if you have it
- Brand: Biomerieux
- Product: VITEK 2 Compact (version numbers 8.01, 8.02 (8.0x) and 9.01, 9.02 (9.0x))
- Configuration: External communication configured to HL7
- Units affected: 6777 systems
The hazard
BioMérieux identified a potential safety risk where the worst case is a false susceptible erroneous test result. The problem occurs when HL7 Connection is used, causing results in the VITEK 2 to not match those sent to the LIS, or preventing expert interpretation results and Therapeutic Corrections from being sent if an isolate is sent more than once.
Context
GovInfoNow's records show Biomerieux Inc has 36 other recalls on record since 2017-07-12. Other recent recalls of similar products include Biomerieux VITEK 2 AST-N461 Test Kit Recall (2026-07-24), Biomerieux VITEK 2 AST-N447 Kit Recall (2026-06-04), and Biomerieux VITEK 2 Gram-negative Susceptibility Cards May Give False Antibiotic Results (2026-01-05). Other recent recalls of similar products include HardyDisk AST Cefiderocol 30μg FDC30: False Susceptibility Results Risk (2026-06-08), BioFire Respiratory Panel 2.1 Recall: False Negatives Risk (2025-10-22), and Vivoo Vaginal pH Test Recall: False Results Risk Inappropriate Medical Treatment (2025-11-22).